Skip to main content

and
  1. Article

    Open Access

    Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

    The impact of genetic variability of pharmacogenes as a possible risk factor for adverse drug reactions is elucidated in the EMPAR (Einfluss metabolischer Profile auf die Arzneimitteltherapiesicherheit in der ...

    Jochen Fracowiak, Tatjana Huebner, Steffen Heß in The Pharmacogenomics Journal (2022)